Fenamates inhibit contraction of guinea-pig isolated bronchus in vitro independent of prostanoid synthesis inhibition

Life Sciences

Volumn 62, Issue 19, 1998, Pages 289-294

  Li, Liang ^b   Vapaatalo, Heikki ^b   Vaali, Kirsi ^b   Paakkari, Ilari ^b   Kankaanranta, Hannu ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NONE

Author keywords

Bronchus; Flufenamic acid; Guinea pig; Indomethacin; Tolfenamic acid; Verapamil

Indexed keywords

CALCIUM ION; FLUFENAMIC ACID; INDOMETACIN; METHACHOLINE; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; TOLFENAMIC ACID; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; GUINEA PIG; NONHUMAN;

ANIMALIA; BRONCHUS; CAVIA PORCELLUS; SUS SCROFA;

EID: 0032478687     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00146-5     Document Type: Article

References (20)

1. 1. J.R. VANE, and R.M. BOTTING, Inflamm. Res. 44 1-10 (1995).
2. 2. J.R. MCLEAN and M.I. GLUCKMAN, Drug Res. 33 627-631 (1983).
3. 3. T. CORELL, Pharmacol. Toxicol. 75 (Suppl 2) 14-21 (1994).
4. 4. H. VAPAATALO, J. PARANTAINEN, I-B. LINDEN and H. HAKKARAINEN, Headache, New Vistas, F Sicuteri (Ed), 287-300. Biochemical Press, Florence (1977).
5. 5. E. MOILANEN and H. KANKAANRANTA, Pharmacol. Toxicol. 75 (Suppl 2) 60-63 (1994).
6. 6. P. MCDOUGALL, A. MARKHAM, I. CAMERON and A.J. SWEETMAN, Biochem. Pharmacol. 37 1327-1330 (1988).
7. 7. S. CHEN, R. INOUE and Y. ITO, Br. J. Pharmacol. 109 793-801 (1993).
8. 8. H. KANKAANRANTA and E. MOILANEN, Mol. Pharmacol. 47 1006-1013 (1995).
9. 9. R.W. FOSTER, B.I. OKPALUGO and R.C. SMALL, Br. J. Pharmacol. 81 499-507 (1984).
10. 10. A.J. KNOX and A.E. TATTERSFIELD, Handbook of Experimental Pharmacology, Vol III, L. Szekeres and J.G. Papp (Eds), 405-443. Springer Verlag Berlin Heidelberg, Berlin (1994).
11. 11. R.J. MARTHAN, C. MARTIN, T. AMEDEE and J. MIRRONEAU, J. Appl. Physiol. 66 1706-1714 (1989).
12. 12. T. HISADA, Y. KURACHI and T. SUGIMOTO, Pflügers Arch. 416 151-161 (1990).
13. 13. C. ADVENIER, J. CERRINA, P. DUROUX, A. FLOCH, and A. RENIER, Br. J. Pharmacol. 82 727-733 (1984).
14. 14. B.J. NORTHOVER, Br. J. Pharmacol. 100 477-82 (1990).
15. 15. E.R. CHILVERS, B.J. LYNCH and R.A.J. CHALLISS, Pharmac. Ther. 62 221-245 (1994).
16. 16. R.K. MURRAY, and M.I. KOTLIKOFF, J. Physiol. 435 123-144 (1991).
17. 17. R.K. MURRAY, B.K. FLEISCHMANN and M.I. KOTLIKOFF, Am. J. Physiol. 264 C485-490 (1993).
18. 18. M. TOMASIC, J.P. BOYLE, J.F. WORLEY and M.I. KOTLIKOFF, Am. J. Physiol. 263 C106-113 (1992).
19. 19. A. LÓPEZ BERNAL, S. BUCKLEY, C.M.P. REES and J.M. MARSHALL, J. Endocrinol. 129 439-445 (1991).
20. 20. J. VANE and R. BOTTING, Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors, J. Vane, J. Botting and R. Botting (Eds), 1-27. Kluwer Academic Publishers and William Harvey Press, London (1996).